Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date	Views
	Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsy Journal:Endocrinology, Diabetes and Metabolism Case Reports	Herle, PratimaBoyages, StevenHui, RinaNahar, NajmunNgui, Nicholas K.	2020
	Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial Journal:Clinical Breast Cancer	Chan, ArleneMoy, BeverlyMansi, JanineEjlertsen, BentHolmes, Frankie AnnChia, StephenIwata, HirojiGnant, MichaelLoibl, SibylleBarrios, Carlos H.Somali, IsilSmichkoska, SnezhanaMartinez, NoeliaAlonso, Mirta GarciaLink, John S.Mayer, Ingrid A.Cold, SørenMurillo, Serafin MoralesSenecal, FrancisInoue, KenichiRuiz-Borrego, ManuelHui, RinaDenduluri, NeelimaPatt, DebraRugo, Hope S.Johnston, Stephen R.D.Bryce, RichardZhang, BoXu, FengWong, AlvinMartin, Miguel	2021
	Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio Journal:Breast	Lee, Clara InkyungLow, Siew KeeMaldonado, RicardoFox, PeterBalakrishnar, BavanthiCoulter, Sallyde Bruijn, PeterKoolen, Stijn L.W.Gao, BoLynch, JodiZdenkowski, NicholasHui, RinaLiddle, ChristopherMathijssen, Ron H.J.Wilcken, NicholasWong, MarkGurney, Howard	2020
	Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial Journal:Annals of Oncology	Paz-Ares, L.Spira, A.Raben, D.Planchard, D.Cho, B. C.Özgüroğlu, M.Daniel, D.Villegas, A.Vicente, D.Hui, R.Murakami, S.Spigel, D.Senan, S.Langer, C. J.Perez, B. A.Boothman, A. M.Broadhurst, H.Wadsworth, C.Dennis, P. A.Antonia, S. J.Faivre-Finn, C.	2020
	Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology	de Boer, RichardHui, RinaLim, ElgeneYeo, BelindaZdenkowski, Nicholas	2020
	Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Journal:The Lancet Oncology	Garassino, Marina C.Gadgeel, ShirishEsteban, EmilioFelip, EnriquetaSperanza, GiovannaDomine, ManuelHochmair, Maximilian J.Powell, StevenCheng, Susanna Yee ShanBischoff, Helge G.Peled, NirReck, MartinHui, RinaGaron, Edward B.Boyer, MichaelWei, ZiwenBurke, ThomasPietanza, M. CatherineRodríguez-Abreu, Delvys	2020
	Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer Journal:Journal of Clinical Oncology	Gadgeel, ShirishRodríguez-Abreu, DelvysSperanza, GiovannaEsteban, EmilioFelip, EnriquetaDómine, ManuelHui, RinaHochmair, Maximilian J.Clingan, PhilipPowell, Steven F.Yee-Shan Cheng, SusannaBischoff, Helge G.Peled, NirGrossi, FrancescoJennens, Ross R.Reck, MartinGaron, Edward B.Novello, SilviaRubio-Viqueira, BelénBoyer, MichaelKurata, TakayasuGray, Jhanelle E.Yang, JingBas, TubaPietanza, M. CatherineGarassino, Marina C.	2020
	Pembrolizumab for early triple-negative breast cancer Journal:New England Journal of Medicine	Schmid, P.Cortes, J.Pusztai, L.McArthur, H.Kümmel, S.Bergh, J.Denkert, C.Park, Y. H.Hui, R.Harbeck, N.Takahashi, M.Foukakis, T.Fasching, P. A.Cardoso, F.Untch, M.Jia, L.Karantza, V.Zhao, J.Aktan, G.Dent, R.O'Shaughnessy, J.	2020
	Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC Journal:Journal of Thoracic Oncology	Gray, Jhanelle E.Villegas, AugustoDaniel, DaveyVicente, DavidMurakami, ShujiHui, RinaKurata, TakayasuChiappori, AlbertoLee, Ki HyeongCho, Byoung ChulPlanchard, DavidPaz-Ares, LuisFaivre-Finn, CorinneVansteenkiste, Johan F.Spigel, David R.Wadsworth, CatherineTaboada, MariaDennis, Phillip A.Özgüroğlu, MustafaAntonia, Scott J.	2020
	Lucitanib for the treatment of HR<sup>þ</sup>/HER2<sup>-</sup> Metastatic breast cancer: Results from the multicohort phase II FINESSE study Journal:Clinical Cancer Research	Hui, RinaPearson, AlexCortes, JavierCampbell, ChristinePoirot, CamilleAzim, Hatem A.Fumagalli, DeboraLambertini, MatteoDaly, FergusArahmani, AmalPerez-Garcia, JoséAftimos, PhilippeBedard, Philippe L.Xuereb, LauraScheepers, Elsemieke D.Vicente, MalouGoulioti, TheodoraLoibl, SibylleLoi, SherenePierrat, Marie JeanneTurner, Nicholas C.Andre, FabriceCurigliano, Giuseppe	2020
	Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study Journal:The Lancet Oncology	Hui, RinaÖzgüroğlu, MustafaVillegas, AugustoDaniel, DaveyVicente, DavidMurakami, ShujiYokoi, TakashiChiappori, AlbertoLee, Ki Hyeongde Wit, MaikeCho, Byoung ChulGray, Jhanelle E.Rydén, AnnaViviers, LouisPoole, LynneZhang, YiduoDennis, Phillip A.Antonia, Scott J.	2019
	Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases Journal:Journal of Pain and Symptom Management	Yee, JasmineDavis, Glen M.Hackett, DanielBeith, Jane M.Wilcken, NicholasCurrow, DavidEmery, JonPhillips, JaneMartin, AndrewHui, RinaHarrison, MichelleSegelov, EvaKilbreath, Sharon L.	2019
	Five-year overall survival for patients with advanced non-small-cell lung cancer treated with pembrolizumab: Results from the phase i KEYNOTE-001 study Journal:Journal of Clinical Oncology	Garon, Edward B.Hellmann, Matthew D.Rizvi, Naiyer A.Carcereny, EnricLeighl, Natasha B.Ahn, Myung JuEder, Joseph PaulBalmanoukian, Ani S.Aggarwal, CharuHorn, LeoraPatnaik, AmitaGubens, MatthewRamalingam, Suresh S.Felip, EnriquetaGoldman, Jonathan W.Scalzo, CathieJensen, ErinKush, Debra A.Hui, Rina	2019
	Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy? Journal:Breast	Lee, Clara I.Fox, PeterBalakrishnar, BavanthiBalleine, Rosemary L.Gao, BoProvan, PamelaCoulter, SallyLiddle, ChristopherHui, RinaWong, MarkGurney, HowardWilcken, Nicholas	2019
	Rate of cancer progression as a predictive marker of efficacy of immunotherapy; An analysis in metastatic non-small-cell lung cancer Journal:Immunotherapy	Prasanna, ThiruArasaratnam, MalBoyer, MichaelMcNeil, CatrionaBarnet, Megan B.Asher, RebeccaHui, RinaNagrial, AdnanKao, Steven	2019
	Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study Journal:The Lancet Respiratory Medicine	Leighl, Natasha B.Hellmann, Matthew D.Hui, RinaCarcereny, EnricFelip, EnriquetaAhn, Myung JuEder, Joseph PaulBalmanoukian, Ani S.Aggarwal, CharuHorn, LeoraPatnaik, AmitaGubens, MatthewRamalingam, Suresh S.Lubiniecki, Gregory M.Zhang, JinPiperdi, BilalGaron, Edward B.	2019
	Updated analysis of KEYNOTE-024: Pembrolizumab versus platinum-based chemotherapy for advanced non–small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater Journal:Journal of Clinical Oncology	Reck, MartinRodríguez-Abreu, DelvysRobinson, Andrew G.Hui, RinaCsoszi, TiborFülöp, AndreaGottfried, MayaPeled, NirTafreshi, AliCuffe, SineadO’Brien, MaryRao, SumanHotta, KatsuyukiVandormael, KristelRiccio, AntonioYang, JingCatherine Pietanza, M.Brahmer, Julie R.	2019
	Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial Journal:The Lancet Oncology	Loi, ShereneGiobbie-Hurder, AnitaGombos, AndreaBachelot, ThomasHui, RinaCurigliano, GiuseppeCampone, MarioBiganzoli, LauraBonnefoi, HervéJerusalem, GuyBartsch, RupertRabaglio-Poretti, ManuelaKammler, RoswithaMaibach, RudolfSmyth, Mark J.Di Leo, AngeloColleoni, MarcoViale, GiuseppeRegan, Meredith M.André, FabriceFumagalli, DeboraGelber, Richard D.Goulioti, TheodoraHiltbrunner, AnitaHui, RitaRoschitzki, HeidiRuepp, BarbaraBoyle, FranStahel, RolfAebi, StefanCoates, Alan S.Goldhirsch, AronKarlsson, PerKössler, IngridFournarakou, StamatinaGasca, AdrianaPfister, RitaRibeli-Hofmann, SabrinaWeber, MagdelenaCelotto, DanielaComune, CarmenFrapolli, MichelaSánchez-Hohl, MagdalenaHuang, HuiMahoney, CaitlinPrice, KarenScott, KarolynShaw, HollyFischer, SusanGreco, MonicaKing, ColleenAndrighetto, StefaniaPiccart-Gebhart, MartineFindlay, HeatherJenkins, MichelleKarantza, VassilikiMejia, JaimeSchneier, Patrick	2019
	Patterns of care for stage III non–small cell lung cancer in Australia Journal:Asia-Pacific Journal of Clinical Oncology	Parente, PhillipChan, Bryan A.Hughes, Brett G.M.Jasas, KevinJoshi, RohitKao, StevenHegi-Johnson, FionaHui, RinaMcLaughlin-Barrett, SaraNordman, InaStone, Emily	2019
	Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Journal:Asia-Pacific Journal of Clinical Oncology	Boyle, FrancesBeith, JaneBurslem, Katiede Boer, RichardHui, RinaLim, ElgeneMcCarthy, NicoleRedfern, AndrewWoodward, Natasha	2018